Global Nasopharyngeal Carcinoma Market Size, Share, and COVID-19 Impact Analysis, By Therapy (Chemotherapy, Immunotherapy, Radiation Therapy, Other Therapy), By End Users (Hospitals & Clinics, Ambulatory Surgery Centers, Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030

Industry: Healthcare
RELEASE DATE Mar 2023
REPORT ID SI1616
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis by Therapy
      2. Market Attractiveness Analysis by Type
      3. Market Attractiveness Analysis by End Users
      4. Market Attractiveness Analysis by Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising the number of cases
    3. Restraints
      1. High cost of therapeutic procedures
    4. Opportunities
      1.  Early detection and screening
    5. Challenges

5.5.1.   Side effects and toxicity

  1. Global Nasopharyngeal Carcinoma Market Analysis and Projection, By Therapy
    1. Segment Overview
    2. Chemotherapy
    3. Immunotherapy
    4. Radiation Therapy
    5. Other Therapy
  2. Global Nasopharyngeal Carcinoma Market Analysis and Projection, By Type
    1. Segment Overview
    2. Surgery
    3. Radiation
    4. Chemotherapy
  3. Global Nasopharyngeal Carcinoma Market Analysis and Projection, By End Users
    1. Segment Overview
    2. Hospitals & Clinics
    3. Ambulatory Surgery Centers
    4. Others
  4. Global Nasopharyngeal Carcinoma Market, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  5. Global Nasopharyngeal Carcinoma Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Global Nasopharyngeal Carcinoma Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  6. Company Profiles
    1. Biocon Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2. BRISTOL MYERS SQUIBB COMPANY
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Cyclacel Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4. F. Hoffman La-Roche Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.  Merck & Co., Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6. Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7. Pfizer, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. GlaxoSmithKline (GSK) PLC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9. Sanofi
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Theravectys SA
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11. Eli Lilly and Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12. Roche
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13. BioDiem
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  2. Global Chemotherapy, Nasopharyngeal Carcinoma Market, By Region, 2022-2032(USD Billion)
  3. Global Immunotherapy, Nasopharyngeal Carcinoma Market, By Region, 2022-2032(USD Billion)
  4. Global Radiation Therapy, Nasopharyngeal Carcinoma Market, By Region, 2022-2032(USD Billion)
  5. Global Other Therapy, Nasopharyngeal Carcinoma Market, By Region, 2022-2032(USD Billion)
  6. Global Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  7. Global Surgery, Nasopharyngeal Carcinoma Market, By Region, 2022-2032(USD Billion)
  8. Global Radiation, Nasopharyngeal Carcinoma Market, By Region, 2022-2032(USD Billion)
  9. Global Chemotherapy, Nasopharyngeal Carcinoma Market, By Region, 2022-2032(USD Billion)
  10. Global Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  11. Global Hospitals & Clinics, Nasopharyngeal Carcinoma Market, By Region, 2022-2032(USD Billion)
  12. Global Ambulatory Surgery Centers, Nasopharyngeal Carcinoma Market, By Region, 2022-2032(USD Billion)
  13. Global Others, Nasopharyngeal Carcinoma Market, By Region, 2022-2032(USD Billion)
  14. Global Nasopharyngeal Carcinoma Market, By Region, 2022-2032(USD Billion)
  15. North America Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  16. North America Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  17. North America Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  18. U.S. Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  19. U.S. Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  20. U.S. Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  21. Canada Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  22. Canada Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  23. Canada Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  24. Mexico Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  25. Mexico Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  26. Mexico Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  27. Europe Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  28. Europe Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  29. Europe Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  30. Germany Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  31. Germany Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  32. Germany Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  33. France Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  34. France Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  35. France Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  36. U.K. Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  37. U.K. Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  38. U.K. Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  39. Italy Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  40. Italy Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  41. Italy Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  42. Spain Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  43. Spain Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  44. Spain Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  45. Asia Pacific Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  46. Asia Pacific Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  47. Asia Pacific Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  48. Japan Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  49. Japan Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  50. Japan Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  51. China Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  52. China Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion) 
  53. China Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  54. India Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  55. India Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  56. India Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  57. South America Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  58. South America Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  59. South America Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  60. Brazil Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  61. Brazil Nasopharyngeal Carcinoma Market, By Surgery, 2022-2032(USD Billion)
  62. Brazil Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  63. The Middle East and Africa Nasopharyngeal Carcinoma Market, Drug Class, 2022-2032(USD   Billion)
  64. The Middle East and Africa Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD   Billion)
  65. The Middle East and Africa Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)
  66. UAE Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  67. UAE Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  68. UAE Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion) 
  69. South Africa Nasopharyngeal Carcinoma Market, By Therapy, 2022-2032(USD Billion)
  70. South Africa Nasopharyngeal Carcinoma Market, By Type, 2022-2032(USD Billion)
  71. South Africa Nasopharyngeal Carcinoma Market, By End Users, 2022-2032(USD Billion)

List of Figures 

  1. Global Nasopharyngeal Carcinoma Market Segmentation
  2. Nasopharyngeal Carcinoma Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Nasopharyngeal Carcinoma Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Nasopharyngeal Carcinoma Market
  20. Nasopharyngeal Carcinoma Market Segmentation, By Therapy
  21. Nasopharyngeal Carcinoma Market, For Chemotherapy, By Region, 2022-2032 ($ Billion)
  22. Nasopharyngeal Carcinoma Market, For Immunotherapy, By Region, 2022-2032 ($ Billion)
  23. Nasopharyngeal Carcinoma Market, For Radiation Therapy, By Region, 2022-2032 ($ Billion)
  24. Nasopharyngeal Carcinoma Market, For Others Therapy, By Region, 2022-2032 ($ Billion
  25. Nasopharyngeal Carcinoma Market Segmentation, By Type
  26. Nasopharyngeal Carcinoma Market, For Surgery, By Region, 2022-2032 ($ Billion)
  27. Nasopharyngeal Carcinoma Market, For Radiation, By Region, 2022-2032 ($ Billion)
  28. Nasopharyngeal Carcinoma Market, For Chemotherapy, By Region, 2022-2032 ($ Billion)
  29. Nasopharyngeal Carcinoma Market Segmentation, By End Users
  30. Nasopharyngeal Carcinoma Market, For Hospitals & Clinics, By Region, 2022-2032 ($ Billion)
  31. Nasopharyngeal Carcinoma Market, For Ambulatory Surgery Centers, By Region, 2022-2032 ($ Billion)
  32. Nasopharyngeal Carcinoma Market, For Others, By Region, 2022-2032 ($ Billion)
  33. Biocon Limited: Net Sales, 2022-2032 ($ Billion)
  34. Biocon Limited: Revenue Share, By Segment, 2022 (%)
  35. Biocon Limited: Revenue Share, By Region, 2022 (%)
  36. BRISTOL MYERS SQUIBB COMPANY: Net Sales, 2022-2032 ($ Billion)
  37. BRISTOL MYERS SQUIBB COMPANY: Revenue Share, By Segment, 2022 (%)
  38. BRISTOL MYERS SQUIBB COMPANY: Revenue Share, By Region, 2022 (%)
  39. Cyclacel Pharmaceuticals: Net Sales, 2022-2032 ($ Billion)
  40. Cyclacel Pharmaceuticals: Revenue Share, By Segment, 2022 (%)
  41. Cyclacel Pharmaceuticals: Revenue Share, By Region, 2022 (%)
  42. F. Hoffman La-Roche Ltd.: Net Sales, 2022-2032 ($ Billion)
  43. F. Hoffman La-Roche Ltd.: Revenue Share, By Segment, 2022 (%)
  44. F. Hoffman La-Roche Ltd.: Revenue Share, By Region, 2022 (%)
  45. Merck & Co., Inc.: Net Sales, 2022-2032 ($ Billion)
  46. Merck & Co., Inc.: Revenue Share, By Segment, 2022 (%)
  47. Merck & Co., Inc.: Revenue Share, By Region, 2022 (%)
  48. Novartis AG: Net Sales, 2022-2032 ($ Billion)
  49. Novartis AG: Revenue Share, By Segment, 2022 (%)
  50. Novartis AG: Revenue Share, By Region, 2022 (%)
  51. Pfizer, Inc.: Net Sales, 2022-2032 ($ Billion)
  52. Pfizer, Inc.: Revenue Share, By Segment, 2022 (%)
  53. Pfizer, Inc.: Revenue Share, By Region, 2022 (%)
  54. GlaxoSmithKline (GSK) PLC: Net Sales, 2022-2032 ($ Billion)
  55. GlaxoSmithKline (GSK) PLC: Revenue Share, By Segment, 2022 (%)
  56. GlaxoSmithKline (GSK) PLC: Revenue Share, By Region, 2022 (%)
  57. Sanofi: Net Sales, 2022-2032 ($ Billion)
  58. Sanofi: Revenue Share, By Segment, 2022 (%)
  59. Sanofi: Revenue Share, By Region, 2022 (%)
  60. Theravectys SA.: Net Sales, 2022-2032 ($ Billion)
  61. Theravectys SA.: Revenue Share, By Segment, 2022 (%)
  62. Theravectys SA.: Revenue Share, By Region, 2022 (%)
  63. Eli Lilly And Company: Net Sales, 2022-2032 ($ Billion)
  64. Eli Lilly And Company: Revenue Share, By Segment, 2022 (%)
  65. Eli Lilly And Company: Revenue Share, By Region, 2022 (%)
  66. Roche: Net Sales, 2022-2032 ($ Billion)
  67. Roche: Revenue Share, By Segment, 2022 (%)
  68. Roche: Revenue Share, By Region, 2022 (%)
  69. BioDiem: Net Sales, 2022-2032 ($ Billion)
  70. BioDiem: Revenue Share, By Segment, 2022 (%)
  71. BioDiem: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2021
Tables & Figures:100
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:5.6%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies